Prevention, awareness and infrastructure
Across the world, and particularly in developing countries, people affected by certain diseases face stigma and discrimination, disability and a vicious cycle of ill health and poverty.
Diseases that can be prevented, managed, or cured cause significant suffering and mortality due to a lack of basic knowledge and inadequate health services.
To improve healthcare access and support people in vulnerable communities, we make targeted product and financial donations to programmes run by local and global partners that are designed to be sustainable in the long term. We also partner with NGOs to tackle some of the root causes of disease and ill health. Our philosophy is to support health and educational programmes that are innovative, sustainable and produce tangible results.
Save the Children
We have an innovative ten-year partnership with Save the Children to help save one million children’s lives. We are combining GSK’s scientific and manufacturing expertise with Save the Children’s on-the-ground experience to find new ways to help bring down the number of children dying from preventable and treatable diseases. In the next few years, by focusing on running long-term health programmes, strengthening countries’ healthcare systems, finding new treatments and advocating for global change, we can help build a world where no child under the age of five dies from preventable causes.
To date, we have reached over 2.98 million children in 46 countries through our partnership. Over 114,000 children under-five have been fully immunised and over 282,000 children have been treated for diarrhoea, malaria or pneumonia. Find out more about our partnership with Save the Children
Our partnership programme with Save the Children in Nigeria aims to contribute to an accelerated reduction in child deaths from preventable infectious disease, with an emphasis on childhood pneumonia. Through our INtegrated Sustainable childhood Pneumonia and Infectious disease Reduction In NiGeria (INSPIRING) programme, launched in June 2018, we will build on our strong partnership and utilise the talent and insights of our GSK and Save the Children country offices, as well as the legacy of health programmes we’ve supported together since 2015.
Although infectious disease-related deaths can be prevented thanks to existing treatment options and vaccinations, this isn’t always the case in many places around the world. In Nigeria, pneumonia alone causes over 130,000 deaths per year and kills 350 children every single day.
“By investing £7.5 million in Nigeria’s health system over five years, the GSK and Save the Children partnership will catalyse change in infectious disease deaths through a virtuous cycle of awareness, mobilisation and empowerment, reinforced by high impact research, strategic advocacy and technical assistance”, explains Matt MacCalla, Manager, GSK and Save the Children partnership. “As its name suggests, the programme is truly inspiring and will make a difference to thousands of lives.”Back to top
We've reached over 2.98 million children through our partnership with Save the Children
Meet Baby Mckline
The first baby born at a healthcare facility in Bungoma County, Kenya, supported through our partnership with Save the Children.
Healthcare worker training
The world is expected to be short of 18 million health workers by 2030; the shortage is most acute in the world’s poorest countries and is recognised as one of the most fundamental barriers to good health. A fully trained and well-supported community health worker can effectively deliver treatments for common childhood illnesses and provide health education reaching up to 500 children in a year.
ViiV Healthcare’s Positive Action programmes continue to make great progress through community partnerships, connections and collaborations with the broader HIV community. Funding enables these communities to:
- tackle stigma and discrimination and reduce violence against at-risk populations
- test innovations in education, care and treatment
- build the grassroots capacity of these disproportionately affected communities.
The Frontline Health Worker Programme is a partnership between GSK, Amref Health Africa, CARE International and Save the Children, which is working to address the chronic global shortage of health workers.
It is an ambitious partnership, implementing sustainable healthcare programmes in communities across Africa and Asia and advocating for affordable, quality healthcare, for everyone, everywhere.
Our programmes train frontline health workers not only to treat individuals but to connect communities to the wider health system, for example, by helping people access more specialised healthcare outside of their community. Our partnership represents one of the biggest private sector-NGO partnerships in the world focused on frontline health workers. Since 2009, together, we have invested £43 million, funded by GSK, to train over 86,000 frontline health workers in 44 countries.
Every year millions of people are displaced by disasters and emergency situations. These crises can devastate families, leaving them without access to adequate food, shelter or healthcare. GSK works with partners and humanitarian organisations to prepare for and respond to emergency situations. In some instances, we fast-track the development of life-saving vaccines, and in others, we contribute by donating cash, products and our employees’ time. We also invest in long-term rebuilding and reconstruction in the aftermath of a disaster.
GSK Consumer Healthcare, with its heritage in specialist oral health, supports Smile Train, a world-leading charity which empowers local medical professionals to provide free, life-changing surgery and comprehensive cleft care to children with cleft lip and palate in more than 90 countries. We have been providing Smile Train with valuable funding, support and expertise to help more children living with clefts lead full and productive lives, as well as helping increase awareness and education about cleft.
Our PULSE Volunteer Partnership provides a skills-based volunteering opportunity for eligible GSK employees to be matched with a non-profit organisation for three or six months full-time.
Find out more
Using our science for global health
Using our scientific expertise, partnerships and global reach to make products available for people who need them, wherever they live
Preparing for future disease threats
We work to tackle some of the root causes of disease and contribute to healthier communities around the world
Pricing and access strategies
We are making our products affordable and available to more people around the world
Improving health globally
Millions of people live with unmet healthcare needs. We want to help change this, using our scientific expertise, our partnerships and our global reach.